索引超出了数组界限。
[1] Deckelbaum LI, Natarajan MK, Bittl JA, et al. Effect of
intracoronary saline infusion on dissection during excimer
laser coronary angioplasty: a randomized trial. The
Percutaneous Excimer Laser Coronary Angioplasty (PELCA)
Investigators[J]. J Am Coll Cardiol, 1995, 26(5):1264-1269.
[2] Topaz O, Das T, Dahm J, et al. Excimer laser revascularisation:
current indications, applications and techniques[J]. Lasers
Med Sci, 2001, 16(2):72-77.
[3] Bittl JA, Sanborn TA, Yardley DE, et al. Predictors of
outcome of percutaneous excimer laser coronary angioplasty
of saphenous vein bypass graft lesions. The Percutaneous
Excimer Laser Coronary Angioplasty Registry[J]. Am J
Cardiol, 1994, 74(2):144-148.
[4] Topaz O, Shah R, Mohanty PK, et al. Application of excimer
laser angioplasty in acute myocardial infarction[J]. Lasers
Surg Med, 2001, 29(2):185-192.
[5] Patel SM, Pokala NR, Menon RV, et al. Prevalence and
treatment of "balloon-uncrossable" coronary chronic total
occlusions[J]. J Invasive Cardiol, 2015, 27(2):78-84.
[6] Fernandez JP, Hobson AR, McKenzie D, et al. Beyond the
balloon: excimer coronary laser atherectomy used alone or in
combination with rotational atherectomy in the treatment of
chronic total occlusions, non-crossable and non-expansible
coronary lesions[J]. EuroIntervention, 2013, 9(2):243-250.
[7] Mehran R, Mintz GS, Satler LF, et al. Treatment of instent
restenosis with excimer laser coronary angioplasty:
mechanisms and results compared with PTCA alone[J].
Circulation, 1997, 96(7):2183-2189.
[8] Rawlins J, Din JN, Talwar S, et al. Coronary intervention
with the excimer laser: review of the technology and outcome
data[J]. Interv Cardiol, 2016, 11(1):27-32.
[9] Dahm JB, Kuon E, Vogelgesang D, et al. Relation of degree
of laser debulking of in-stent restenosis as a predictor of
restenosis rate[J]. Am J Cardiol, 2002, 90(1):68-70.
[10] Li H, Ai H, Li L, et al. The therapeutic effects of excimer laser
coronary atherectomy therapy for in-stent restenosis chronic
total occlusions[J]. BMC Cardiovasc Disord, 2021, 21(1):399.
[11] Sonoda S, Morino Y, Ako J, et al. Impact of final stent
dimensions on long-term results following sirolimus-eluting
stent implantation: serial intravascular ultrasound analysis
from the sirius trial[J]. J Am Coll Cardiol, 2004, 43(11):1959-
1963.
[12] Cheneau E, Leborgne L, Mintz GS, et al. Predictors of
subacute stent thrombosis: results of a systematic intravascular
ultrasound study[J]. Circulation, 2003, 108(1):43-47.
[13] Lam SCC, Bertog S, Sievert H. Excimer laser in management
of underexpansion of a newly deployed coronary stent[J].
Catheter Cardiovasc Interv, 2014, 83(1):E64-E68.
[14] Karacsonyi J, Armstrong EJ, Truong HTD, et al. Contemporary
use of laser during percutaneous coronary interventions:
insights from the laser veterans affairs (LAVA) multicenter
registry[J]. J Invasive Cardiol, 2018, 30(6):195-201.
[15] Moussa I, Di Mario C, Moses J, et al. Coronary stenting
after rotational atherectomy in calcified and complex lesions.
Angiographic and clinical follow-up results[J]. Circulation,
1997, 96(1):128-136.
[16] Gilutz H, Weinstein JM, Ilia R. Repeated balloon rupture
during coronary stenting due to a calcified lesion: an
intravascular ultrasound study[J]. Catheter Cardiovasc Interv,
2000, 50(2):212-214.
[17] Nakano MST, Otsuka F, Yahagi K, et al. Human autopsy
study of drug-eluting stents restenosis: histomorphological
predictors and neointimal characteristics[J]. Eur Heart J, 2013,
34(42):3304-3313.
[18] Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion
and residual reference segment stenosis are related to stent
thrombosis after sirolimus-eluting stent implantation: an
intravascular ultrasound study[J]. J Am Coll Cardiol, 2005,
45(7):995-998.
[19] Généreux P, Madhavan MV, Mintz GS, et al. Ischemic
outcomes after coronary intervention of calcified vessels
in acute coronary syndromes. Pooled analysis from
the HORIZONS-AMI (Harmonizing Outcomes With
Revascularization and Stents in Acute Myocardial Infarction)
and ACUITY (Acute Catheterization and Urgent Intervention
Triage Strategy) TRIALS[J]. J Am Coll Cardiol, 2014,
63(18):1845-1854.
[20] Bourantas CV, Zhang YJ, Garg S, et al. Prognostic implications
of coronary calcification in patients with obstructive coronary
artery disease treated by percutaneous coronary intervention: a
patient-level pooled analysis of 7 contemporary stent trials[J].
Heart, 2014, 100(15):1158-1164.
[21] Protty MB, Gallagher S, Farooq V, et al. Combined use of
rotational and excimer lASER coronary atherectomy (RASER)
during complex coronary angioplasty—an analysis of cases
(2006-2016) from the British Cardiovascular Intervention
Society database[J]. Catheter Cardiovasc Interv, 2021,
97(7):E911-E918.
[22] Madyoon H, Croushore L. Application of excimer laser
coronary angioplasty (ELCA) in bifurcation lesions[J]. Lasers
Med Sci, 2001, 16(2):108-112.
[23] Hada M, Sugiyama T, Kanaji Y, et al. Primary percutaneous
coronary intervention for a left main bifurcation lesion
without stenting using excimer laser with optical coherence
tomography guidance: a case report[J]. Eur Heart J Case Rep,
2020, 4(1):1-6.
[24] Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty
in acute myocardial infarction (the CARMEL multicenter trial)
[J]. Am J Cardiol, 2004, 93(6):694-701.
[25] Nishino M, Mori N, Takiuchi S, et al. Indications and
outcomes of excimer laser coronary atherectomy: efficacy and
safety for thrombotic lesions—the ULTRAMAN registry[J]. J
Cardiol, 2017, 69(1):314-319.
[26] AbuShady MM, Mohamady Y, Enany B, et al. Prevalence of
prediabetes in patients with acute coronary syndrome: impact
on in-hospital outcomes[J]. Intern Med J, 2015, 45(2):183-
188.
[27] Shibata N, Takagi K, Morishima I, et al. The impact of the
excimer laser on myocardial salvage in ST-elevation acute
myocardial infarction via nuclear scintigraphy[J]. Int J
Cardiovasc Imaging, 2020, 36(1):161-170.
[28] Giugliano GR, Falcone MW, Mego D, et al. A prospective
multicenter registry of laser therapy for degenerated saphenous
vein graft stenosis: the COronary graft Results following
Atherectomy with Laser (CORAL) trial[J]. Cardiovasc Revasc
Med, 2012, 13(2):84-89.
[29] Baim DS, Wahr D, George B, et al. Randomized trial of
a distal embolic protection device during percutaneous
intervention of saphenous vein aorto-coronary bypass grafts[J].
Circulation, 2002, 105(11):1285-1290.
[30] Mohandes M, Rojas S, Torres M, et al. Percutaneous coronary
intervention of chronically occluded saphenous vein grafts
using excimer laser atherectomy as an adjuvant therapy[J].
Cardiovasc Revasc Med, 2017, 18(6S1):2-6.
[31] Ebisawa S, Miyashita YSE, Saigusa T, et al. Successful
prevention of no-reflow phenomenon in a high-risk patient
using excimer laser coronary atherectomy[J]. Cardiovasc
Interv Ther, 2013, 28(4):422-425.
[32] Kadohira T, Schwarcz AI, De Gregorio J. Successful retrieval
of an entrapped guide wire between a deployed coronary
stent and severely calcified vessel wall using excimer laser
coronary atherectomy[J]. Catheter Cardiovasc Interv, 2015,
85(2):E39-E42.
[33] Savvoulidis P, Bagur R, Ybarra LF. Retrieval of undeflatable
stent balloon using laser energy[J]. Cardiovasc Revasc Med,
2021, 28S:136-139.
[34] Almasoud A, Walters D, Mahmud E. Robotically performed
excimer laser coronary atherectomy: proof of feasibility[J].
Catheter Cardiovasc Interv, 2018, 92(4):713-716.
[35] Nikolsky E, Pucelikova T, Mehran R, et al. An evaluation
of fluoroscopy time and correlation with outcomes after
percutaneous coronary intervention[J]. J Invasive Cardiol,
2007, 19(5):208-213.
[36] Bansal A, Gupta S, Jain V, et al. Adverse events related to
excimer laser coronary atherectomy: analysis of the FDA
MAUDE database[J]. Cardiovasc Revasc Med, 2021, 27:
88-89.